Search Results
Found 1 results
510(k) Data Aggregation
(325 days)
The R&D Body Fluid-I Control is an assayed hematology control intended to monitor the reliability of hematology instruments that quantitatively measure red and white blood cell counts in cerebrospinal fluids, serous fluids, and synovial fluids.
For in vitro Diagnostic Use Only
The R&D Body Fluid-I is an assayed, in vitro, whole blood control composed of human and bovine cells in a plasma-like fluid with preservatives. Three levels are available and each level of control is packaged in a tube containing 3 mL of the control material. It is sampled in the same manner as a patient specimen.
The provided text describes the R&D Body Fluid-I Hematology Control, an in vitro diagnostic device. This device is a quality control material, not a diagnostic algorithm, and therefore the acceptance criteria and study design elements typically associated with AI/ML-based diagnostic devices (like sample size for test sets, ground truth establishment by experts, MRMC studies, or standalone performance) are not applicable in this context. The study performed is a stability and reproducibility study for a control material, not a clinical study to assess diagnostic accuracy.
Here's an analysis based on the provided text, focusing on the available information:
1. Table of Acceptance Criteria and Reported Device Performance
| Acceptance Criteria | Reported Device Performance |
|---|---|
| Closed vial stability: Remain within range over life of product (75 days claimed) | "The Body Fluid-I Hematology Control passed the acceptance criteria of remaining within range over the life of the product." "It meets the claim of a 75 day closed vial..." |
| Open vial stability: Remain within range over life of product (30 days claimed) | "The Body Fluid-I Hematology Control passed the acceptance criteria of remaining within range over the life of the product." "...and 30 day open vial stability..." |
| Lot-to-lot reproducibility/consistency | "The R&D Systems Body Fluid-I Hematology Control is as safe and effective as the predicate device and is an effective quality control material for evaluating the accuracy and precision of hematology instruments... results confirm lot-to-lot consistency." (Implies meeting an internal standard for consistency) |
2. Sample Size Used for the Test Set and Data Provenance
- Sample Size: "Three lots were tested to verify the closed vial and open vial stability and lot to lot reproducibility." Each lot contained 3 levels of control material. The specific number of individual samples tested per lot/level or the total number of measurements is not explicitly provided.
- Data Provenance: The studies were internal validation studies conducted by R&D Systems, Inc. The data is prospective, generated specifically for these validation tests. The country of origin for the data generation would be the USA, where R&D Systems, Inc. is located.
3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts
- This question is not applicable as the device is a quality control material, not a diagnostic algorithm. Ground truth, in the sense of a clinical diagnosis or expert-labeled data, is not established for this type of product. The "ground truth" for a control material is its expected target values and ranges, which are determined by the manufacturer through rigorous testing and assaying on reference instruments.
4. Adjudication Method for the Test Set
- This question is not applicable. Adjudication methods like 2+1 or 3+1 are used for resolving disagreements among multiple human readers on diagnostic tasks. This device is a control material, and its performance is assessed against predefined statistical ranges and stability profiles, not through expert consensus on qualitative interpretation.
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done, If So, What Was the Effect Size of How Much Human Readers Improve with AI vs Without AI Assistance
- This question is not applicable. An MRMC study is designed to evaluate the impact of an AI diagnostic tool on human reader performance. This device is a quality control material and does not involve AI or human interaction in a diagnostic capacity that would necessitate such a study.
6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done
- This question is not applicable. A standalone performance study evaluates a diagnostic algorithm's accuracy independent of human intervention. The R&D Body Fluid-I Hematology Control is a physical control material, not a software algorithm. Its "performance" is its ability to maintain its assayed values within specified ranges over time and under various conditions.
7. The Type of Ground Truth Used
- The "ground truth" for this device (a hematology control) is its assigned target values and acceptable ranges for red and white blood cell counts. These values are established by the manufacturer through repeated measurements on calibrated reference instruments. The acceptance criteria for stability and reproducibility are defined relative to these established target values and ranges.
8. The Sample Size for the Training Set
- This question is not applicable. This device is not an AI/ML algorithm that requires a training set.
9. How the Ground Truth for the Training Set Was Established
- This question is not applicable. As it's not an AI/ML algorithm, there is no training set or associated ground truth in that context.
Ask a specific question about this device
Page 1 of 1